Unity Biotechnology, Inc.UBXNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank28
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
-7.65%
↓ 54% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
-4.96%
Historical baseline
| Period | Value |
|---|---|
| Q1 2025 | -7.65% |
| Q4 2024 | -13.71% |
| Q3 2024 | -13.29% |
| Q2 2024 | 11.56% |
| Q1 2024 | 31.58% |
| Q4 2023 | -6.32% |
| Q3 2023 | 35.71% |
| Q2 2023 | 2.06% |
| Q1 2023 | -8.78% |
| Q4 2022 | 4.59% |
| Q3 2022 | 27.24% |
| Q2 2022 | -0.09% |
| Q1 2022 | -197.30% |
| Q4 2021 | 56.79% |
| Q3 2021 | 13.42% |
| Q2 2021 | 10.89% |
| Q1 2021 | 10.56% |
| Q4 2020 | 2.69% |
| Q3 2020 | 11.57% |
| Q2 2020 | 21.83% |
| Q1 2020 | -54.03% |
| Q4 2019 | 6.18% |
| Q3 2019 | 11.05% |
| Q2 2019 | 6.11% |
| Q1 2019 | -56.96% |
| Q4 2018 | 6.50% |
| Q3 2018 | 23.27% |
| Q2 2018 | -54.16% |
| Q1 2018 | -0.49% |
| Q4 2017 | -25.54% |
| Q3 2017 | 9.24% |
| Q2 2017 | -28.37% |
| Q1 2017 | 0.00% |